Stanford University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).
Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.
Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.
Top-decile sponsor footprint
Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,744 total, page 34 of 35
Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECT
NCT00285818
Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes
NCT00186004
T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis
NCT01078337
Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
NCT00313027
A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer
NCT00186108
A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma
NCT00226980
Rosiglitazone-Induced Weight Gain
NCT00225225
Stress, Diurnal Cortisol, and Breast Cancer Survival
NCT00226967
Apnea Positive Pressure Long-Term Efficacy Study
NCT00051363
Quality of Life Following Radical Prostatectomy
NCT00373308
Spanish Diabetes Self-Management Program
NCT00496145
Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?
NCT00186264
Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma
NCT00055783
Memory and Mental Health in Aging
NCT00043589
Biological CVD Risk Factors in Older Depressed Patients
NCT00318864
Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
NCT00185835
Cyberknife Precision Radiation Delivery System for Tumors of the Spine
NCT00185666
Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)
NCT00185523
Effects of Advertising on Young Children's Perception of Taste
NCT00185536
Effectiveness of Binge Eating Disorder Treatments
NCT00060762
Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium When Compared to Propofol or Midazolam in Cardiac Surgery Patients
NCT00417664
Endovascular Repair of Abdominal Aortic Aneurysms
NCT00803075
Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
NCT00568906
Consent for Obtaining Additional Bone Marrow Specimens at Time of Diagnostic Bone Marrow Procedure
NCT01048060
"does Myobloc™ Improve Functional Hand USE IN Young Children With A Hypertonic Upper Extremity?"
NCT00238641
Endovascular Repair of Descending Thoracic Aortic Aneurysms
NCT00802984
Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders
NCT00186576
Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.
NCT00185952
A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
NCT00186433
Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer
NCT00255060
To Evaluate the Safety and Efficacy for GORE TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Disease
NCT00757003
Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease
NCT00225173
Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease
NCT00388349
Bevacizumab in Treating Patients With Myelodysplastic Syndrome
NCT00022048
Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
NCT00025142
Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia
NCT01108497
Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
NCT00026208
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
NCT01034865
Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma
NCT00006009
Citalopram in Irritable Bowel Syndrome
NCT00477165
Reducing Eating Disorder Risk Factors
NCT00050570
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment
NCT00398372
Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study
NCT00185809
Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma
NCT00185653
Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample
NCT00568438
Obesity, Weight Loss, and Cardiovascular Disease Risk
NCT00186459
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
NCT00186121
Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
NCT00185913
Alternative Support for Rural and Isolated Women in an HMO
NCT00186212
Allogeneic Transplantation From Related Haploidentical Donors
NCT00185692
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 209 |
| Phase 3 | 51 |
| Phase 4 | 86 |
Therapeutic Areas
What is open in the Stanford University pipeline
264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).
Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.